REGENXBIO, Inc. (RGNX)
9.28
-0.04
(-0.43%)
USD |
NASDAQ |
Sep 02, 10:58
REGENXBIO Cash from Operations (Annual) : -123.96M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -123.96M |
| December 31, 2024 | -173.12M |
| December 31, 2023 | -218.41M |
| December 31, 2022 | -207.49M |
| December 31, 2021 | 218.88M |
| December 31, 2020 | -54.06M |
| December 31, 2019 | -107.70M |
| Date | Value |
|---|---|
| December 31, 2018 | 104.65M |
| December 31, 2017 | -57.99M |
| December 31, 2016 | -48.56M |
| December 31, 2015 | -22.48M |
| December 31, 2014 | -2.399M |
| December 31, 2013 | -3.012M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| AbbVie, Inc. | 19.03B |
| Capricor Therapeutics, Inc. | -69.81M |
| Biogen, Inc. | 2.205B |
| United Therapeutics Corp. | 1.561B |
| Ardelyx, Inc. | -42.48M |